Prognostic significance of elevated serum tumor markers (STM) after the first cycle of chemotherapy in patients with intermediate and poor risk non seminomatous testicular germ cell tumors (NSGCT)

被引：0
|
作者：
Batra, A. [1 ]
Nayak, B. [2 ]
Singh, P. [2 ]
Sahoo, R. K. [2 ]
Kunhiparambath, H. [3 ]
Kaushal, S. [4 ]
Seth, A. [2 ]
Varshney, A. N. [1 ]
Raj, A. [1 ]
机构：
[1] All India Inst Med Sci, Dept Med Oncol, New Delhi, India
[2] All India Inst Med Sci, Urol, New Delhi, India
[3] All India Inst Med Sci, Dept Radiotherapy & Oncol, New Delhi, India
[4] All India Inst Med Sci, Pathol, New Delhi, India
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.643
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
515P
引用
收藏
页码：S778 / S778
页数：1
相关论文
共 50 条
  • [1] Prognostic significance of raised serum tumor markers (STM) after 2 cycles of chemotherapy in men with intermediate- and poor-risk non-seminomatous testicular germ cell tumors (NSGCT) treated at a single-centre in India.
    Varshney, Ankur Nandan
    Raj, Abhishek
    Sahoo, Ranjit Kumar
    Haresh, K. P.
    Singh, Prabhjot
    Shamim, Ahmed Shamim
    Seth, Amlesh
    Kaushal, Seema
    Das, Chandan Krushna
    Batra, Atul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Results of multimodality therapy in poor risk non-seminomatous germ cell tumors (NSGCT)
    Omuro, Y
    Sasaki, E
    Hayashi, C
    Okamoto, R
    Kobayashi, T
    Maeda, Y
    Sasaki, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 430 - 430
  • [3] First-line high-dose chemotherapy for 'poor risk' metastatic non-seminomatous testicular germ cell tumors
    Bokemeyer, C
    Harstrick, A
    Beyer, J
    Metzner, B
    Rüther, U
    Hartmann, JT
    Holstein, K
    Derigs, HG
    de Wit, R
    Casper, J
    Schöffski, P
    Kührer, I
    Illiger, HJ
    Kempf, B
    Reichle, A
    Föller, A
    Hossfeld, DK
    Fischer, JT
    Berdel, W
    Gerhartz, H
    Kirchner, H
    Pflüger, K
    Ostermann, H
    Kanz, L
    Schmoll, HJ
    ONKOLOGIE, 1998, 21 : 23 - 25
  • [4] Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors
    Inanc, SE
    Meral, R
    Darendeliler, E
    Yasasever, V
    Onat, H
    ACTA ONCOLOGICA, 1999, 38 (04) : 505 - 509
  • [5] Chemotherapy for poor prognosis non seminomatous germ cell tumors (NSGCT): Should doses be reduced at first cycle to prevent acute respiratory distress syndrome (ARDS) in patients with multiple lung metastases?
    Fizazi, K.
    Massard, C.
    Postel-Vinay, S.
    Escudier, B.
    Culine, S.
    Raynard, B.
    Blot, F.
    Antoun, S.
    Nitenberg, G.
    Plantade, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] INTENSIVE INDUCTION CHEMOTHERAPY FOR POOR RISK NON-SEMINOMATOUS GERM-CELL TUMORS
    HORWICH, A
    BRADA, M
    NICHOLLS, J
    JAY, G
    HENDRY, WF
    DEARNALEY, D
    PECKHAM, MJ
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02): : 177 - 184
  • [7] A phase II trial of paclitaxel, ifosfamid and cisplatin in patients with poor-prognosis disseminated non-seminomatous germ cell tumors with unfavorable serum tumor marker decline after first cycle of chemotherapy
    Mego, M.
    Svetlovska, D.
    Rejlekova, K.
    Miskovska, V.
    De Angelis, V.
    Kalavska, K.
    Obertova, J.
    Palacka, P.
    Sycova-Mila, Z.
    Chovanec, M.
    Mardiak, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S600 - S600
  • [8] Prognostic reclassification and survival outcomes in intermediate- and poor-risk nonseminomatous germ cell tumors (NSGCT)
    Jobanputra, Kunal Naishadh
    Prakash, Gagan
    Arora, Amandeep
    Jadhav, Bhagyashri
    Pal, Mahendra
    Pawar, Akash
    Dey, Sayak
    Bakshi, Ganesh
    Murthy, Vedang
    Maitre, Priyamvada
    Menon, Nandini Sharrel
    Shah, Minit Jalan
    Menon, Santosh
    Popat, Palak
    Ringe-Katdare, Aparna
    Sable, Nilesh
    Agrawal, Archi
    Noronha, Vanita
    Prabhash, Kumar
    Joshi, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] NON-SEMINOMATOUS GERM-CELL TESTICULAR-TUMORS - RESIDUAL MASSES AFTER CHEMOTHERAPY
    LEVITT, MD
    REYNOLDS, PM
    SHEINER, HJ
    BYRNE, MJ
    BRITISH JOURNAL OF SURGERY, 1985, 72 (01) : 19 - 22
  • [10] Severity of bleomycin-induced lung toxicity in Indian patients with intermediate and poor-risk non-seminomatous germ cell tumors (NSGCT): A clinical perspective.
    Gujarathi, Himanshu
    Dhanawat, Aditya
    Jadhav, Bhagyashri
    Tiwari, Atul
    Jobanputra, Kunal Naishadh
    Kriti, Y. C.
    Rane, Pallavi
    Shah, Minit Jalan
    Menon, Nandini Sharrel
    Maitre, Priyamvada
    Pal, Mahendra
    Arora, Amandeep
    Ringe-Katdare, Aparna
    Menon, Santosh
    Prakash, Gagan
    Murthy, Vedang
    Noronha, Vanita
    Prabhash, Kumar
    Tandon, Saneep
    Joshi, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
12345